Metabolism of 3′-deoxy-3′-[F-18]fluorothymidine in proliferating A549 cells: Validations for positron emission tomography-Reference-Cited by-同舟云学术

Metabolism of 3′-deoxy-3′-[F-18]fluorothymidine in proliferating A549 cells: Validations for positron emission tomography

Published:2004-10 Issue:7 Volume:31 Page:829-837
ISSN:0969-8051
Container-title:Nuclear Medicine and Biology
language:en
Short-container-title:Nuclear Medicine and Biology

Author:

Grierson John R.,Schwartz Jeffery L.,Muzi Mark,Jordan Robert,Krohn Kenneth A

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Molecular Medicine

Reference50 articles.

1. In-vivo validation of [F-18]FLT (3′deoxy-3′-fluorothymidine) as a proliferation imaging tracer in humans: correlation of FLT uptake by positron emission tomography with Ki-67 immunohistochemistry and flow cytometry in human lung tumors;Vesselle;Clin Cancer Res,2002

2. 3-Deoxy-3-[18F]fluorothymidine-positron emission tomography for the noninvasive assessment of proliferation in pulmonary nodules;Buck;Cancer Res,2002

3. 18F-Fluorothymidine radiation dosimetry in human imaging studies;Vesselle;J Nucl Med,2003

4. Potential impact of [18F]3′-deoxy-3′-fluorothymidine versus [18F]fluoro-2-deoxy-D-glucose in positron emission tomography of colorectal cancer;Francis;Eur J Nucl Med Mol Imag,2003

5. [18F]FLT PET for diagnosis and staging of thoracic tumours;Dittmann;Eur J Nucl Med Mol Imag,2003

Cited by 94 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploration of Imaging Biomarkers for Metabolically-Targeted Osteosarcoma Therapy in a Murine Xenograft Model;Cancer Biotherapy and Radiopharmaceuticals;2023-09-01

2. Molecular Imaging in Oncology;Molecular Imaging and Targeted Therapy;2023

3. Radiopharmaceuticals for Molecular Imaging;Molecular Imaging and Targeted Therapy;2023

4. Diagnostic Applications of Nuclear Medicine: Brain Tumors;Nuclear Oncology;2022

5. Diagnostic Applications of Nuclear Medicine: Brain Tumors;Nuclear Oncology;2022